Toll Free: 1-888-928-9744
Published: Sep, 2014 | Pages:
44 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Vichem Chemie Research Ltd. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Vichem Chemie Research Ltd. - Product Pipeline Review - 2014', provides an overview of the Vichem Chemie Research Ltd.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Vichem Chemie Research Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Vichem Chemie Research Ltd. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Vichem Chemie Research Ltd.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Vichem Chemie Research Ltd.'s pipeline products Reasons to buy - Evaluate Vichem Chemie Research Ltd.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Vichem Chemie Research Ltd. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Vichem Chemie Research Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Vichem Chemie Research Ltd. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Vichem Chemie Research Ltd. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Vichem Chemie Research Ltd. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 5 Vichem Chemie Research Ltd. Snapshot 6 Vichem Chemie Research Ltd. Overview 6 Key Information 6 Key Facts 6 Vichem Chemie Research Ltd. - Research and Development Overview 7 Key Therapeutic Areas 7 Vichem Chemie Research Ltd. - Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products - Monotherapy 11 Pipeline Products - Partnered Products 12 Partnered Products/Combination Treatment Modalities 13 Vichem Chemie Research Ltd. - Pipeline Products Glance 15 Vichem Chemie Research Ltd. - Early Stage Pipeline Products 15 Preclinical Products/Combination Treatment Modalities 15 Discovery Products/Combination Treatment Modalities 16 Vichem Chemie Research Ltd. - Drug Profiles 17 Small Molecules to Inhibit CDK9 for HIV-1 Infection 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 VI-4053 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 VI-4055 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 VI-460 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 VI-87 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 VID-45110 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 AX-20017 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 Cancer Stem Cell Killing Program 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Small Molecule to Inhibit EGFR for Oncology 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 VI-11498 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 VI-11527 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 VI-11530 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 VI-11562 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 VI-14585 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 VI-15843 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 VI-15910 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 VI-16665 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 VI-17299 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 VI-18469 35 Product Description 35 Mechanism of Action 35 R&D Progress 35 VI-9376 36 Product Description 36 Mechanism of Action 36 R&D Progress 36 Vichem Chemie Research Ltd. - Pipeline Analysis 37 Vichem Chemie Research Ltd. - Pipeline Products by Target 37 Vichem Chemie Research Ltd. - Pipeline Products by Route of Administration 38 Vichem Chemie Research Ltd. - Pipeline Products by Molecule Type 39 Vichem Chemie Research Ltd. - Pipeline Products by Mechanism of Action 40 Vichem Chemie Research Ltd. - Dormant Projects 41 Vichem Chemie Research Ltd. - Locations And Subsidiaries 42 Head Office 42 Appendix 43 Methodology 43 Coverage 43 Secondary Research 43 Primary Research 43 Expert Panel Validation 43 Contact Us 44 Disclaimer 44
List of Tables Vichem Chemie Research Ltd., Key Information 6 Vichem Chemie Research Ltd., Key Facts 6 Vichem Chemie Research Ltd. - Pipeline by Indication, 2014 8 Vichem Chemie Research Ltd. - Pipeline by Stage of Development, 2014 10 Vichem Chemie Research Ltd. - Monotherapy Products in Pipeline, 2014 11 Vichem Chemie Research Ltd. - Partnered Products in Pipeline, 2014 12 Vichem Chemie Research Ltd. - Partnered Products/ Combination Treatment Modalities, 2014 13 Vichem Chemie Research Ltd. - Preclinical, 2014 15 Vichem Chemie Research Ltd. - Discovery, 2014 16 Vichem Chemie Research Ltd. - Pipeline by Target, 2014 37 Vichem Chemie Research Ltd. - Pipeline by Route of Administration, 2014 38 Vichem Chemie Research Ltd. - Pipeline by Molecule Type, 2014 39 Vichem Chemie Research Ltd. - Pipeline Products by Mechanism of Action, 2014 40 Vichem Chemie Research Ltd. - Dormant Developmental Projects,2014 41
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.